Neurocrine Biosciences
A Program Manager at Neurocrine Biosciences leads strategic program management in early development, ensuring alignment of preclinical plans, regulatory strategy, and operational activities to enable IND/CTA submissions and FIH study initiation. The role involves cross-functional collaboration with research, CMC, clinical, regulatory, and commercial teams to develop and execute integrated program strategies.
Headquarters
San Diego, California, United States
Company Size
1001-5000 employees
Founded
1992
Neurocrine Biosciences is a biopharmaceutical company focused on discovering and developing treatments for patients with neurological, psychiatric, endocrine, and immunological disorders. With over 30 years of research, the company works to bring hope to people living with rare diseases and conditions that lack viable treatment options. Neurocrine develops and markets approved medicines while maintaining an active clinical pipeline across multiple therapeutic areas.
Neurocrine Biosciences to Present at the Stifel 2026 Virtual CNS Forum
1 day ago
Magnetar Financial LLC Acquires New Holdings in Neurocrine Biosciences, Inc. $NBIX
5 hours ago
Is It Time To Reassess Neurocrine Biosciences (NBIX) After The Recent Share Price Pullback
23 hours ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Neurocrine Biosciences.
Neurocrine Biosciences didn’t post a salary, so this is our estimate from similar listings.
15% above the average for this role
Capital Fund Management S.A. Has $17.37 Million Holdings in Neurocrine Biosciences, Inc. $NBIX
7 hours ago
Assistant Lead, TCR Discovery
C0000274692P
Manager, RA CMC
AbbVie
Senior Associate, Regulatory Affairs
MapLight Therapeutics
Director/Senior Director, Nonclinical Safety
Nimbus Therapeutics
Director, Regulatory Affairs CMC
Corcept Therapeutics
Director, Regulatory Affairs Strategy - Genetics Medicine
Regeneron Pharmaceuticals